Posters

Pharmacist-Driven Program for Evaluation of Pneumococcal Vaccination Among Adult Patients with Cystic Fibrosis 216 115 Shields Health Solutions

Pharmacist-Driven Program for Evaluation of Pneumococcal Vaccination Among Adult Patients with Cystic Fibrosis

This study highlights why engaging with a pharmacist during clinic visits facilitates appropriate immunization and supports adult patients with cystic fibrosis (PwCF).  

Evaluation of Pharmacist-Led Clinical Interventions for Mavacamten within an Integrated Health System Specialty Pharmacy Care Model 216 115 Shields Health Solutions

Evaluation of Pharmacist-Led Clinical Interventions for Mavacamten within an Integrated Health System Specialty Pharmacy Care Model

This study explores how a pharmacist-led mavacamten clinical management program ensures proactive management and identification of clinical and safety issues for patients on this complex therapy, as demonstrated by clinical…

Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacies 216 115 Shields Health Solutions

Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacies

    Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.  

Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medications 216 115 Shields Health Solutions

Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medications

    This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.  

Evaluating Health System Time Demands and Challenges of Specialty Pharmacy Accreditation 216 115 Shields Health Solutions

Evaluating Health System Time Demands and Challenges of Specialty Pharmacy Accreditation

    This poster evaluate the challenges, time commitments, and resource allocation associated withachieving and maintaining SP accreditation among health-system specialty pharmacies.  

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy

  This poster evaluates existing oral oncology medication waste events among patients filling at a health system specialty pharmacy (HSSP).  

Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancer 216 115 Shields Health Solutions

Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancer

    This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.  

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy

 This poster evaluates the clinical and quality outcomes of a bleeding disorder program in a health system specialty pharmacy.  

The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivity 216 115 Shields Health Solutions

The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivity

  This poster assesses the impact of re-training for specialty pharmacy outreach technicians by evaluating improvements in compliance knowledge, technician productivity, and patient enrollment rates.  

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program 216 115 Shields Health Solutions

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program

  This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led hypertrophic cardiomyopathy (HCM) clinical management program.